Brought to you by 
Alzheimer’s diagnostic start-up Neurotrack completes $2mm Series A financing
01 Nov 2013
Executive Summary
Founders Fund led a $2mm Series A round for Neurotrack Inc., which aims to market a pre-symptomatic Alzheimer’s diagnostic. Twelve other investors participated, including the Social+Capital Partnership and individual angels Peter Thiel and Chamath Palihapitiya.
Deal Industry
- In Vitro Diagnostics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Alzheimer’s diagnostic start-up Neurotrack completes $2mm Series A financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice